000 01457 a2200445 4500
005 20250513194109.0
264 0 _c19991217
008 199912s 0 0 eng d
022 _a0304-3959
024 7 _a10.1016/s0304-3959(99)00105-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHosoi, M
245 0 0 _aProstaglandin E(2) has antinociceptive effect through EP(1) receptor in the ventromedial hypothalamus in rats.
_h[electronic resource]
260 _bPain
_cNov 1999
300 _a221-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnalgesics
_xadministration & dosage
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aBrain Mapping
650 0 4 _aDinoprostone
_xadministration & dosage
650 0 4 _aHindlimb
650 0 4 _aMale
650 0 4 _aMicroinjections
650 0 4 _aPain
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aReaction Time
650 0 4 _aReceptors, Prostaglandin E
_xdrug effects
650 0 4 _aReceptors, Prostaglandin E, EP1 Subtype
650 0 4 _aVentromedial Hypothalamic Nucleus
_xdrug effects
700 1 _aOka, T
700 1 _aAbe, M
700 1 _aHori, T
700 1 _aYamamoto, H
700 1 _aMine, K
700 1 _aKubo, C
773 0 _tPain
_gvol. 83
_gno. 2
_gp. 221-7
856 4 0 _uhttps://doi.org/10.1016/s0304-3959(99)00105-0
_zAvailable from publisher's website
999 _c10491493
_d10491493